MY181172A - Composite preparation comprising active ingredient-containing film coating layer - Google Patents

Composite preparation comprising active ingredient-containing film coating layer

Info

Publication number
MY181172A
MY181172A MYPI2016002270A MYPI2016002270A MY181172A MY 181172 A MY181172 A MY 181172A MY PI2016002270 A MYPI2016002270 A MY PI2016002270A MY PI2016002270 A MYPI2016002270 A MY PI2016002270A MY 181172 A MY181172 A MY 181172A
Authority
MY
Malaysia
Prior art keywords
film coating
coating layer
composite preparation
active ingredient
containing film
Prior art date
Application number
MYPI2016002270A
Inventor
Hyung Seo Kim
Jung Hyun Cho
Jin Cheul Kim
Yong Ii Kim
Jae Hyun Park
Jong Soo Woo
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Priority claimed from KR1020150093777A external-priority patent/KR20160002411A/en
Publication of MY181172A publication Critical patent/MY181172A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

.Provided are a composite preparation and a method for producing same, the composite preparation comprising a core containing a first active ingredient; and a film coating layer containing a 5-a-reductase inhibitor, wherein the film coating layer is formed by coating with a film coating solution in which the film coating materials are dissolved in a mixed solvent of water and about 30-80 wt% of an organic solvent with respect to a total weight of the mixed solvent.
MYPI2016002270A 2014-06-30 2015-06-30 Composite preparation comprising active ingredient-containing film coating layer MY181172A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20140081223 2014-06-30
KR1020150093777A KR20160002411A (en) 2014-06-30 2015-06-30 COMPOSITE FORMULATION COMPRISING 5-α-REDUCTASE INHIBITOR-CONTAINING FILM COATING LAYER AND A PROCESS FOR THE PREPARATION THEREOF

Publications (1)

Publication Number Publication Date
MY181172A true MY181172A (en) 2020-12-21

Family

ID=55019633

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016002270A MY181172A (en) 2014-06-30 2015-06-30 Composite preparation comprising active ingredient-containing film coating layer

Country Status (2)

Country Link
MY (1) MY181172A (en)
WO (1) WO2016003180A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20231543T1 (en) * 2018-05-19 2024-03-01 Zim Laboratories Limited Novel pharmaceutical composition of tamsulosin and dutasteride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005016981A1 (en) * 2005-04-13 2006-10-19 Bayer Healthcare Ag Combination therapy for benign prostatic hyperplasia
MX2012007448A (en) * 2009-12-22 2012-09-12 Abbott Healthcare Private Ltd Controlled release pharmaceutical composition.
WO2012127495A2 (en) * 2011-02-28 2012-09-27 Titan Laboratories Pvt. Ltd. A pharmaceutical composition and process for preparation thereof
KR101310710B1 (en) * 2011-03-23 2013-09-27 한미약품 주식회사 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
KR20140013436A (en) * 2012-07-24 2014-02-05 한미약품 주식회사 Composite formulation for oral administration comprising metformin and rosuvastatin

Also Published As

Publication number Publication date
WO2016003180A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
PH12016502536B1 (en) Composite preparation comprising 5-a-reductase inhibitor-containing film coating layer, and method for producing the composite preparation
CL2017000288A1 (en) Encapsulation of biologically active hydrophobic compounds
CL2015002164A1 (en) Combined formulation of two antiviral compounds.
CL2013003576A1 (en) Pharmaceutical composition comprising nilotinib; dosage form comprising nilotinib; method to prepare nilotinib; method for preparing the dosage form; and use of an organic acid to increase the bioavailability of nilotinib and to suppress the effect of the food associated with the pharmaceutical composition.
CL2017003067A1 (en) Substituted pyridines and method of use
CL2013002504A1 (en) Solid coated pharmaceutical preparation comprising at least one active ingredient and because the coating has a thickness of 0.1 to 100 nm, preferably 0.3 to 50 nm and more preferably 0.5 to 35 nm; and its method of preparation
AR102563A1 (en) DENSIFIED COMPOSITION FOR THE TREATMENT OF A UNDERGROUND FORMATION
CO6660482A2 (en) N - [(het)] arilethyl) pyrazole] (uncle) carboximides and their hetero substituted analogs
EP3252152A4 (en) Method for mass producing natural killer cell and use of natural killer cell obtained by the method as anti-cancer agent
UY35047A (en) PROCEDURE FOR PREPARATION OF A SLOW RELEASE FERTILIZER
HK1208677A1 (en) Antiviral compound with imidazole-biphenyl-imidazole core
EP3232114A4 (en) Electrochemical light emitting cell, composition for forming light emitting layer of electrochemical light emitting cell, and ionic compound for light emitting layer of electrochemical light emitting cell
EP3241875A4 (en) Resin composition for hard coating, and hard-coating film comprising cured form of same as coating layer
EP3183232A4 (en) Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation
EP3205924A4 (en) Electrochemical luminescent cell and composition for forming luminescent layer of electrochemical luminescent cell
EP3241824A4 (en) Trifluoroacethydrazide compound as well as preparation method therefor and application thereof in preparing medicament
EP3138834A4 (en) Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient
EA201691741A1 (en) PHARMACEUTICAL COMPOSITION
EP3124442A4 (en) Method for stopping swimming or crawling of adhesion-stage larvae
AR101136A1 (en) PROCESS FOR THE PREPARATION OF 3-HYDROXIPICOLINIC ACIDS
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
HRP20130082A2 (en) Pharmaceutical composition with sustained release of trimetazidine
MX2016009667A (en) Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same.
EP3103475A4 (en) Anticancer adjuvant composition containing rip3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting rip3 expression, and method for monitoring sensitivity of anticancer drug
MY181172A (en) Composite preparation comprising active ingredient-containing film coating layer